Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Catherine Wu
Beth Israel Deaconess Medical Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Neon Therapeutics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
NA
Personalized vaccine for patients with AML
Project Narrative: In the present study, we will conduct a clinical trial evaluating an autologous DC/AML fusion cell vaccine alone and in combination with an anti-PDL1 antibody, evaluating immune response and 2 year relapse free survival. Based on analysis of the AML mutational events, a neo-antigen profile will be generated for each patient and their functional relevance will be interrogated by assessing the native immune response following exposure to the whole cell vaccine. To define biomarkers predictive of response, the immune landscape of the bone marrow microenvironment, presence of AML driver mutations, and noncoding RNAs regulating antigen presentation and costimulation will be interrogated with respect to their correlation with immune response and clinical outcome.
Filed on July 31, 2017.
Tell us what you know about Catherine Wu's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Catherine Wu”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapeutics, Inc. | $100,000 - $149,999 |
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapeutics | $100,000 - $149,999 |
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapeutics | $40,000 - $59,999 |
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapuetics | Value cannot be readily determined |
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapeutics, Inc. | >$600,000 |
| Catherine Wu | Brigham and Women's Hospital | Conflict of Interest | Neon Therapeutics | Value cannot be readily determined |
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapuetics | $100,000 - $149,999 |
| Catherine Wu | Dana Farber Cancer Inst | Conflict of Interest | Neon Therapeutics | Value cannot be readily determined |
| Catherine Wu | Brigham and Women's Hospital | Conflict of Interest | Neon Therapeutics | $100,000 - $149,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.